Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Clinical Oncology

• Publication date

  2007-10-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2007.12.5708PMID 17925563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized controlled trial comparing docetaxel (D)-cisplatin (P) combination with D alone in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): JCOG0207

  2007cited by this paper
• A phase II study of vinoreline (VNR) and carboplatin (CBDCA) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC).

  2006cited by this paper
• A phase II study of weekly paclitaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer.

  2006cited by this paper
• Hand-foot syndrome after dose-dense adjuvant chemotherapy for breast cancer: a case series.

  2006cited by this paper
• Treatment of Elderly Non–small Cell Lung Cancer Patients with Three Different Schedules of Weekly Paclitaxel in Combination with Carboplatin: Subanalysis of a Randomized Trial

  2006cited by this paper
• Chemotherapy for elderly patients with non-small cell lung cancer: a review of the evidence.

  2005cited by this paper
• Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first‐line treatment of advanced nonsmall cell lung carcinoma (TAX 326)

  2005cited by this paper
• Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730).

  2005cited by this paper
• Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.

  2005cited by this paper
• Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer Study Group.

  2005cited by this paper
• Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group.

  2005cited by this paper
• Comparison of pharmacokinetics and pharmacodynamics of docetaxel and Cisplatin in elderly and non-elderly patients: why is toxicity increased in elderly patients?

  2004cited by this paper
• American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

  2004cited by this paper
• Multicenter phase II study of the combination of carboplatin and paclitaxel as first line treatment in elderly patients with advanced non small cell lung cancer (NSCLC).

  2004cited by this paper
• A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients.

  2004cited by this paper
• Efficacy of modified regimen with attenuated doses of paclitaxel plus carboplatin combination chemotherapy in elderly and/or weak patients with advanced non-small cell lung cancer.

  2003cited by this paper
• Elderly Patients with Advanced Non-Small Cell Lung Cancer

  2003cited by this paper
• O-49 Age-specific subanalysis of ECOG 1594: Fit elderly patietns (70–80 yrs) with NSCLC do as well as younger patients (<70)

  2003cited by this paper
• Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer

  2003cited by this paper
• Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer.

  2003cited by this paper
• The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel

  2003cited by this paper
• Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.

  2003cited by this paper
• Re: Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.

  2002cited by this paper
• Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.

  2002cited by this paper
• Single-agent versus combination chemotherapy in advanced non-small cell lung cancer (NSCLC): A CALGB randomized trial of efficacy, quality of life, and cost-effectiveness

  2001cited by this paper
• Global cancer statistics in the year 2000.

  2001cited by this paper
• The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancer.

  2000cited by this paper
• Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group.

  1999cited by this paper
• Optimal flexible designs in phase II clinical trials.

  1998cited by this paper
• Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer

  1997cited by this paper

• Prediction models for severe treatment-related toxicities in older adults with cancer: a systematic review.

  2025cites this paper
• Pooled analysis of oral vinorelbine as single agents in patients with advanced NSCLC

  2025cites this paper
• Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials

  2021cites this paper
• Comparison of Carboplatin Plus Pemetrexed Followed by Maintenance Pemetrexed With Docetaxel Monotherapy in Elderly Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial.

  2020cites this paper
• Pemetrexed and carboplatin combination therapy followed by pemetrexed maintenance in Japanese patients with non-squamous non-small cell lung cancer: A subgroup analysis of elderly patients.

  2019cites this paper
• Elderly patients with advanced NSCLC: The value of geriatric evaluation and the feasibility of CGA alternatives in predicting chemotherapy toxicity.

  2019cites this paper
• Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials.

  2018cites this paper
• Effective nivolumab sequential thoracic radiotherapy in elderly patients with advanced squamous cell lung cancer: did radiation therapy play a role? A case report

  2018cites this paper
• EAGLES study: First-line Bevacizumab in Combination with Chemotherapy in Elderly Patients with Advanced, Metastatic, Non-squamous Non-small Cell Lung Cancer.

  2017cites this paper
• Molecular-targeted therapy for elderly patients with advanced non-small cell lung cancer (Review)

  2016cites this paper
• Molecular-targeted therapy for elderly patients with advanced non-small cell lung cancer.

  2016cites this paper
• Biweekly Carboplatin Plus Gemcitabine as First-Line Treatment of Elderly Patients With Advanced Squamous Non-Small-cell Lung Cancer: A Multicenter Phase I-II Trial by the Hellenic Oncology Research Group.

  2016cites this paper
• Clinical research on chemotherapy in combination with LMWH treatment of advanced lung cancer patients

  2016cites this paper
• Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.

  2016cites this paper
• Lung cancer: A focus on the new lines of management

  2016cites this paper
• Advanced non-small cell lung cancer in elderly patients: A review

  2015cites this paper
• Randomized controlled trial comparing docetaxel-cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207†.

  2015cites this paper
• Pharmacotherapy for treatment of lung cancer in the elderly

  2015cites this paper
• Treatment of Unfit Patients With Advanced Non-Small-Cell Lung Cancer: Definition Criteria According an Expert Panel.

  2015cites this paper
• Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer.

  2014cites this paper
• Is There a Role for Neoadjuvant Chemotherapy in Older Patients

  2013cites this paper
• Cost analysis of erlotinib versus chemotherapy for first-line treatment of non-small-cell lung cancer in frail elderly patients participating in a prospective phase 2 study (GFPC 0505).

  2013cites this paper
• Clinical Epidemiology and the Impact of Comorbidity on Treatment and Outcome

  2013cites this paper
• Platinum doublets as first-line treatment for elderly patients with advanced non-small cell lung cancer

  2013cites this paper
• Predicting toxicity in advanced lung cancer patients treated with platinum-based chemotherapy

  2013cites this paper
• Aging: an important risk factor in chemotherapy-associated vascular diseases

  2013cites this paper
• Increased Risk of High-Grade Hemorrhage in Cancer Patients Treated with Gemcitabine: A Meta-Analysis of 20 Randomized Controlled Trials

  2013cites this paper
• First-Line Treatment and the New Paradigm of Histology-Based Treatment

  2013cites this paper
• Medical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agents.

  2013cites this paper
• Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study.

  2013cites this paper
• Chapter 13 – Chemotherapy-Induced Myelosuppression in the Elderly

  2012cites this paper
• Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 study (GFPC 0504)

  2012cites this paper
• Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 study (GFPC 0504).

  2012cites this paper
• A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study).

  2012cites this paper
• A retrospective analysis comparing the safety and efficacy of chemotherapy in elderly and non‐elderly non‐small‐cell lung cancer patients

  2012cites this paper
• Recurrent non–small-cell lung cancer in elderly patients: a case-based review of current clinical practice

  2012cites this paper
• The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer.

  2012cites this paper
• First-line chemotherapy with planned sequential administration of cisplatin/gemcitabine followed by docetaxel in elderly ‘unfrail’ patients with advanced non-small-cell lung cancer: a multicenter phase II study

  2012cites this paper
• Traitement du cancer bronchique non à petites cellules au stade avancé chez le sujet âgé

  2012cites this paper
• A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study)

  2011cites this paper
• Evaluation of the Efficacy and Safety of the Combination of Gemcitabine and Nedaplatin for Elderly Patients with Advanced Non-Small-Cell Lung Cancer

  2011cites this paper
• Platinum-Based Compounds and Risk for Cardiovascular Toxicity in the Elderly: Role of the Antioxidants in Chemoprevention

  2011cites this paper
• Elderly Patients with Advanced Non-Small Cell Lung Cancer: What Treatment?

  2011cites this paper
• 2010 Consensus on Lung Cancer, new clinical recommendations and current status of biomarker assessment--first-line therapy.

  2011cites this paper
• Non-small cell lung cancer therapy in the elderly.

  2011cites this paper
• Feasibility study for biweekly administration of cisplatin plus gemcitabine as adjuvant-chemotherapy for completely resected non-small cell lung cancer

  2010cites this paper
• Review: Treating advanced non-small cell lung cancer in the elderly

  2010cites this paper
• Update on nonsmall cell lung cancer

  2010cites this paper
• Is age a negative prognostic factor for the treatment of advanced/metastatic non-small-cell lung cancer?

  2010cites this paper
• EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population.

  2010cites this paper
• Vinorelbine for non-small cell lung cancer

  2010cites this paper
• Low Dose Fractionated Cisplatin Plus Gemcitabine for Elderly Patients with Advanced Non Small Cell Lung Cancer: A Retrospective Analysis

  2010cites this paper
• Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial

  2010cites this paper
• Gemcitabine‐based doublets versus single‐agent therapy for elderly patients with advanced nonsmall cell lung cancer

  2009cites this paper
• Epidermal growth factor receptor tyrosine kinase inhibitors in elderly or poor performance status patients with advanced non-small cell lung cancer

  2009cites this paper
• Docetaxel plus gemcitabine as front-line chemotherapy in elderly patients with lung adenocarcinomas: a multicenter phase II study.

  2009cites this paper
• Resveratrol down-regulates survivin and induces apoptosis in human multidrug-resistant SPC-A-1/CDDP cells.

  2009cites this paper
• Lung cancer and treatment in elderly patients: the Achilles Study.

  2009cites this paper
• A phase II trial of pemetrexed and gemcitabine as first line therapy for poor performance status and/or elderly patients with stage IIIB/IV non-small cell lung cancer.

  2009cites this paper
• Therapeutic options for elderly patients with advanced non-small cell lung cancer.

  2009cites this paper
• Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials

  2009cites this paper
• Dose adjustment and supportive care before and during treatment.

  2009cites this paper
• [Chemotherapy of Advanced Non-small Cell Lung Cancer in Elderly Patients.].

  2009cites this paper
• NSCLC in the Elderly—The Legacy of Therapeutic Neglect

  2009cites this paper
• UFT Plus Vinorelbine in Advanced Non-small Cell Lung Cancer: A Phase I and an Elderly Patient-Directed Phase II Study

  2009cites this paper
• Advanced non-small-cell lung cancer in the elderly.

  2009cites this paper
• Dose intensity correlate with survival in elderly patients treated with chemotherapy for advanced non-small cell lung cancer.

  2009cites this paper
• Platinum Compounds in Lung Cancer: Current Status

  2009cites this paper
• Gemcitabine plus cisplatin chemotherapy with concurrent para-toluenesulfonamide local injection therapy for peripherally advanced nonsmall cell lung cancer larger than 3 cm in the greatest dimension

  2009cites this paper
• Management of unfit older patients with advanced NSCLC.

  2009cites this paper
• Cisplatin–vinorelbine chemotherapy in non-small cell lung cancer is safe and well tolerated: results of a retrospective Hungarian clinical data analysis

  2009cites this paper
• Treatment of advanced non-small-cell lung cancer in the elderly.

  2009cites this paper
• A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.

  2008cites this paper
• EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer.

  2008cites this paper
• Non-small cell lung cancer in the elderly - systemic therapy

  2008cites this paper
• Challenges treating older non-small cell lung cancer patients.

  2008cites this paper
• Treatment of patients with advanced non-small-cell lung cancer with performance status of 2: an unsolved issue.

  2008cites this paper
• The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients.

  2008cites this paper
• Overview of clinical trials for lung cancer in the elderly

  2008cites this paper
• Therapeutic Strategy for Treatment of Metastatic Non-Small Cell Lung Cancer

  2008cites this paper
• New insights in drug development for the non-small cell lung cancer therapy.

  2008cites this paper
• Erlotinib for advanced non-small-cell lung cancer in the elderly: an analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21.

  2008cites this paper
• symposium article Challenges treating older non-small cell lung cancer patients

  2008cites this paper
• Rationale and Design of MILES-3 and MILES-4 Studies : Two Randomized Phase 3 Trials Comparing Single-Agent Chemotherapy Versus Cisplatin-Based Doublets in Elderly Patients With Advanced Non e Small-Cell Lung Cancer

  year unknowncites this paper